UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
FERTILITY & IVF

Organon

O

Organon

Fertility & IVFJersey City, United States
Visit Website

About Organon

Spun off from Merck & Co. in 2021, Organon is a global healthcare company built around a focused mission: improving the health of women throughout their lives. Headquartered in Jersey City, New Jersey, Organon trades on the New York Stock Exchange under the ticker OGN and operates across more than 140 countries.

The company's portfolio spans three core segments: women's health, biosimilars, and an established brands portfolio comprising off-patent medicines across cardiovascular, respiratory, dermatology, and other therapeutic areas. In women's health, Organon carries a broad range of contraceptive and reproductive health products, including intrauterine devices, implants, and hormonal contraceptives, making it one of the few global pharmaceutical companies with women's health as its central commercial focus.

Organon's biosimilars portfolio, inherited in part from Merck's oncology and immunology pipeline, includes launched biosimilar versions of major reference biologics, positioning the company as a meaningful participant in the growing global biosimilars market. This segment offers healthcare systems cost-effective access to complex medicines at scale.

With a workforce spanning multiple continents and a particular commercial emphasis on growth markets, Organon has structured its business to address both mature and emerging healthcare environments. Its established brands segment provides stable revenue that supports ongoing investment in women's health innovation and biosimilar development.

Further information is available at organon.com.

Similar Companies

More in Fertility & IVF

C

Cook Medical

Founded in 1963 by Bill Cook from a spare bedroom in Bloomington, Indiana, Cook Medical has grown into one of the world's largest family-owned medical device companies, a distinction that continues to shape its culture and long-term decision-making. Operating independently without the pressure of quarterly earnings reports, the company has remained focused on serving clinicians and patients across a broad portfolio of minimally invasive medical technologies. Minimally Invasive Devices Across Core Specialisms Cook Medical designs, manufactures, and distributes devices used in interventional radiology, endoscopy, urology, vascular surgery, and critical care. Its product catalogue spans thousands of items, including drainage catheters, stents, guidewires, biopsy tools, and endoscopic accessories. The company is particularly well regarded within interventional medicine for the depth of its vascular and biliary ranges, which are used in hospitals and procedural suites worldwide. Global Manufacturing and Distribution Headquartered in Bloomington, Indiana, Cook Medical maintains manufacturing facilities and offices across North America, Europe, Asia Pacific, and beyond, supplying products to more than 135 countries. The company employs tens of thousands of people globally and operates several dedicated business divisions, including Cook Biotech, which focuses on regenerative medicine technologies derived from naturally occurring tissue matrices, and Cook Regentec, which works on cell therapy platforms. Cook Medical has a long-standing reputation for close collaboration with physicians in device development. Many of its products originated from direct partnerships with clinicians who identified unmet procedural needs, a model the company has maintained throughout its history. This approach has led to iterative refinements across its endoscopy and urology portfolios in particular, where the breadth of available configurations allows for high procedural specificity. The company also maintains a strong commitment to training and education, providing simulation resources and hands-on programmes to support adoption of its technologies in clinical settings. Further information is available at cookmedical.com.

View profile
C

CooperSurgical

CooperSurgical has built one of the most comprehensive portfolios in women's health and fertility medicine, spanning devices, diagnostics, and assisted reproductive technology (ART) consumables used by clinicians across the globe. A subsidiary of The Cooper Companies (NYSE: COO), CooperSurgical operates as the dedicated women's health division of a publicly traded corporation headquartered in San Ramon, California. The business focuses on two broad segments: fertility, covering the products and services that support IVF laboratories and ART procedures, and office and surgical, covering gynaecological instruments, uterine health devices, and contraception. The fertility segment is particularly notable. CooperSurgical is widely recognised as a leading supplier to IVF clinics worldwide, offering ART consumables and media used throughout the embryology workflow, from oocyte handling through to embryo culture and transfer. This includes products from acquired brands such as Wallace, Origio, and The LifeGlobal Group, giving the company a broad reach across fertility laboratories in Europe, North America, Asia-Pacific, and beyond. On the surgical and office side, the company supplies instruments and devices for endometrial assessment, minimally invasive gynaecological procedures, and intrauterine contraception, including the well-known PARAGARD copper IUD, which it markets in the United States. CooperSurgical has grown substantially through acquisition, absorbing multiple specialist fertility and gynaecology businesses over the years. It serves healthcare providers ranging from large hospital systems to independent fertility clinics, positioning itself as a single-source partner for women's health product needs. Further information is available at coopersurgical.com.

View profile
H

Hamilton Thorne

Hamilton Thorne has built its reputation as the leading supplier of precision instruments and consumables for the assisted reproductive technology (ART) sector, serving IVF clinics, fertility research laboratories, and pharmaceutical and biotechnology companies worldwide. Founded in 1991 and headquartered in Beverly, Massachusetts, the company develops and markets a portfolio of laser systems, imaging systems, and embryo assessment software designed to improve clinical outcomes in human and animal reproductive medicine. Its LYKOS laser platform and OOSIGHT imaging systems are among the most widely recognised tools in clinical IVF environments globally. Hamilton Thorne is publicly traded on the TSX Venture Exchange under the ticker HLT, giving it a capital markets profile uncommon among specialist ART equipment suppliers. The company has grown significantly through acquisition, adding complementary businesses in consumables, cryopreservation, and laboratory services to build a more complete offering for fertility clinics and research organisations. Its customer base spans fertility clinics, academic research centres, and pharmaceutical companies conducting reproductive toxicology studies. The company also serves the animal breeding and veterinary reproduction market, supplying sperm analysis instruments and related products used in equine, bovine, and companion animal fertility work. Further information is available at hamiltonthorne.com.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy